Cannabis Science, Inc. and Dana Farber Cancer Institute, Inc. Enter Into Historic Research Partnership

IRVINE, CA, May 20, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has entered into a new Research Collaboration Agreement with Dana-Farber Cancer Institute, Inc. to investigate the potential use of a proprietary extract from the JusticiaRead More →

Cannabis Research Forum has a great write-up on what priorities the Massachusetts Cannabis Control Commission has set for itself for 2019. “My hope is to continue building a best practice agency that Massachusetts can be proud of,” CCC Chairman Steven Hoffman told in a statement. Hoffman and the other four commissionersRead More →